IDYA | IDEAYA BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$31.33
-$0.31 (-0.98%)

IDEAYA Biosciences (IDYA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2026, but the two have been closing on each other and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
between the two $31.96 vs 50 $33.90 / 200 $29.41
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 9 Feb 2026 ยท projected 23 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $31.75 vs 50 $35.04 / 200 $36.53
Projection
No cross projected
Test
No active test
Last cross
Death cross 26 Oct 2026 ยท projected 29 bars out

Cross history

19
crosses on record since 2020
9 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
26 Oct 2026Death4-hour29 bars outNot tested
22 Jul 2026Golden steepdaily29 bars outNot tested
1 Jul 2026Golden4-hour25 bars outNot tested
26 May 2026Death moderatedaily27 bars outNot tested
27 Feb 2026Death4-hour22 bars out1 bar cross test

About IDYA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$26.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.